Clinical studies recruiting near Shenyang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Liaoning Provincial People's Hospital · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After R
Phase N/A · Liaoning Cancer Hospital & Institute · Liaoning Cancer Hospital & Institute · NCT06109454 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · The First Hospital of China Medical University · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The First Hospital of China Medical University · Pfizer · NCT07028853 MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
NA · Shengjing Hospital · Shengjing Hospital · NCT05957679 A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
Phase 1 · Liaoning Cancer Hospital · JiaRay Group · NCT06783569 A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · Research Site · AstraZeneca · NCT07404202 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First Hospital of China Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · Liaoning Cancer Hospital & Institute /ID# 268023 · AbbVie · NCT06487559 Nutritional Intervention for Patients With Multiple Cancer Types
NA · The First Affiliated Hospital of China Medical University · First Hospital of China Medical University · NCT06059560 Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Phase N/A · Air Force Hospital of Northern Theater Command · Xingshun Qi · NCT04662918 Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss
NA · The Second Affiliated Hospital of Shenyang Medical College · Shenyang Medical College · NCT07325370 EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE
NA · The Fourth Affiliated Hospital of China Medical University · Shanghai Chest Hospital · NCT06913569 Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
Phase N/A · Shengjing hospital of China medical university · Yu Shi · NCT06849063 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Affiliated Central Hospital Of Shenyang Medical College · Kunming Pharmaceuticals, Inc. · NCT07279493 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Liaoning Cancer Hospital and Institute · Shanghai Henlius Biotech · NCT07160335 The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrh
Phase N/A · Shengjing Hospital of China Medical University · Union Hospital, Tongji Medical College, Huazhong University · NCT07172035 The Chinese Familial Alzheimer's Network
Phase N/A · First Hospital of China Medical University · Capital Medical University · NCT03657732 Mobile Applet for Weight Management in Obese Heart Failure Patients
NA · Shenyang Tenth Hospital · Heart Health Research Center · NCT06455878 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The Peoples Hospital of Liaoning Province · Amgen · NCT07037433 Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Phase 2 · Liaoning Cancer Hospital · Tianjin Medical University Cancer Institute and Hospital · NCT07733830 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (
Phase 3 · The First Hospital of China Medical University · Fudan University · NCT05909332 3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
Phase N/A · Shengjing Hospital of China Medical University · Shengjing Hospital · NCT06205992 The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment S
NA · The First Affiliated Hospital of China Medical University · Beijing Chao Yang Hospital · NCT07136025 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese
Phase 3 · The First Affiliated Hospital of China Medical University · Hoffmann-La Roche · NCT05562947 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · The First Affiliated Hospital of China Medical University · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Phase 1 · Shenyang · SCG Cell Therapy Pte. Ltd. · NCT06617000 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Liaoning Cancer Hospital · Turning Point Therapeutics, Inc. · NCT03093116 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · Shenyang Sixth People's Hospital · Huashan Hospital · NCT05965128 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277

Look up another city

Look up another condition